CD8A and neoplasm: The results revealed that while the JQ1, IL12‐L, and IL12‐H treatments moderately increased the number of tumor‐infiltrating CD8+ T cells, the JQ1+IL12‐L group exhibited a significantly higher level of CD8+ T cell infiltration compared with all the other treatments (all p‐Values <0.05) (Figure 8E,F).